Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8 Code History

Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History